サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1065477

デジタルバイオマーカーの世界市場成長 - 現状と展望（2022年～2028年）

Global Digital Biomarker Market Growth (Status and Outlook) 2022-2028
出版日: | 発行: QYResearch | ページ情報: 英文 96 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
デジタルバイオマーカーの世界市場成長 - 現状と展望（2022年～2028年）
出版日: 2022年03月18日
発行: QYResearch
ページ情報: 英文 96 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルバイオマーカーの市場規模は、2021年に3億8,724万米ドルとなりました。

同市場は、2022年から2028年の間に82.53％のCAGRで推移し、2028年には223億5,791万米ドルに達すると予測されています。

当レポートでは、世界のデジタルバイオマーカー市場について調査し、市場規模や予測、タイプ・用途・企業・地域別の市場分析、市場力学、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポートの概要

  • 調査範囲
  • タイプ別：市場分析
    • 市場規模の成長率（2017 VS 2021 VS 2028）
    • パッシブデジタルバイオマーカー
    • アクティブデジタルバイオマーカー
  • 用途別市場
    • 市場シェア（2017 VS 2021 VS 2028）
    • 臨床疾患
    • 毎日の健康
  • 調査目的
  • 考察年

第2章 世界の成長動向

  • 世界市場の展望（2017-2028）
  • 地域別：成長動向
  • 市場力学
    • 業界の動向
    • 市場の促進要因
    • 市場の課題と抑制要因

第3章 競合別：競合情勢

  • 収益別：世界の主要企業
  • 企業タイプ別：世界の市場シェア（Tier 1、Tier 2、Tier 3）
  • 対象企業：収益別ランキング
  • 市場集中度
  • 主要企業の本社と提供エリア
  • 設立日
  • 合併と買収、拡張計画

第4章 タイプ別：デジタルバイオマーカーの内訳データ

  • 市場規模実績（2017-2022）
  • 市場規模予測（2023-2028）

第5章 用途別：デジタルバイオマーカーの内訳データ

  • 市場規模実績（2017-2022）
  • 市場規模予測（2023-2028）

第6章 北米

  • 市場規模（2017-2028）
  • タイプ別：市場規模
  • 用途別：市場規模
  • 国別：市場規模
    • 市場規模（2017-2022）
    • 市場規模（2023-2028）
    • 米国
    • カナダ

第7章 欧州

  • 市場規模（2017-2028）
  • タイプ別：市場規模
  • 用途別：市場規模
  • 国別：市場規模
    • 市場規模（2017-2022）
    • 市場規模（2023-2028）
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • イタリア

第8章 アジア太平洋

  • 市場規模（2017-2028）
  • タイプ別：市場規模
  • 用途別：市場規模
  • 地域別：市場規模
    • 市場規模（2017-2022）
    • 市場規模（2023-2028）
    • 中国
    • 日本
    • 韓国

第9章 主要企業のプロファイル

  • Philips
  • Johnson &Johnson
  • Pfizer
  • GE Healthcare
  • Novartis
  • Apple
  • Sanofi
  • GlaxoSmithKline
  • Bayer
  • Merck
  • Abbott Laboratories
  • Asahi Kasei
  • Biogen
  • Koneksa Health
  • Roche
  • Huma Therapeutics

第10章 アナリストの見解/結論

第11章 付録

図表

LIST OF TABLES

  • Table 1. Global Digital Biomarker Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
  • Table 2. Global Digital Biomarker Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
  • Table 3. Global Digital Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 4. Global Digital Biomarker Market Size by Region (2017-2022) & (US$ Million)
  • Table 5. Global Digital Biomarker Market Share by Region (2017-2022)
  • Table 6. Global Digital Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 7. Global Digital Biomarker Market Share by Region (2023-2028)
  • Table 8. Digital Biomarker Market Trends
  • Table 9. Digital Biomarker Market Challenges
  • Table 10. Global Digital Biomarker Revenue by Players (2020-2022) & (US$ Million)
  • Table 11. Global Digital Biomarker Market Share by Players (2020-2022)
  • Table 12. Global Top Digital Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2021)
  • Table 13. Ranking of Global Top Digital Biomarker Companies by Revenue (US$ Million) in 2021
  • Table 14. Global 5 Largest Players Market Share by Digital Biomarker Revenue (CR5 and HHI) & (2020-2022)
  • Table 15. Key Players Headquarters and Area Served
  • Table 16. Date of Establishment in Digital Biomarker Market
  • Table 17. Mergers & Acquisitions, Expansion Plans
  • Table 18. Global Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 19. Global Digital Biomarker Revenue Market Share by Type (2017-2022)
  • Table 20. Global Digital Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 21. Global Digital Biomarker Revenue Market Share by Type (2023-2028)
  • Table 22. Global Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 23. Global Digital Biomarker Revenue Market Share by Application (2017-2022)
  • Table 24. Global Digital Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 25. Global Digital Biomarker Revenue Market Share by Application (2023-2028)
  • Table 26. North America Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. North America Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. North America Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. North America Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. North America Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 31. North America Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 32. Europe Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. Europe Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. Europe Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. Europe Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. Europe Digital Biomarker Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. Europe Digital Biomarker Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Asia-Pacific Digital Biomarker Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Asia-Pacific Digital Biomarker Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Asia-Pacific Digital Biomarker Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Asia-Pacific Digital Biomarker Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Asia-Pacific Digital Biomarker Market Size by Region (2017-2022) & (US$ Million)
  • Table 43. Asia-Pacific Digital Biomarker Market Size by Region (2023-2028) & (US$ Million)
  • Table 44. Philips Company Details
  • Table 45. Philips Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 46. Philips Recent Development
  • Table 47. Johnson & Johnson Company Details
  • Table 48. Johnson & Johnson Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 49. Johnson & Johnson Recent Development
  • Table 50. Pfizer Company Details
  • Table 51. Pfizer Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 52. Pfizer Recent Development
  • Table 53. GE Healthcare Company Details
  • Table 54. GE Healthcare Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 55. GE Healthcare Recent Development
  • Table 56. Novartis Company Details
  • Table 57. Novartis Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 58. Novartis Recent Development
  • Table 59. Apple Company Details
  • Table 60. Apple Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 61. Sanofi Company Details
  • Table 62. Sanofi Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 63. GlaxoSmithKline Company Details
  • Table 64. GlaxoSmithKline Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 65. GlaxoSmithKline Recent Development
  • Table 66. Bayer Company Details
  • Table 67. Bayer Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 68. Bayer Recent Development
  • Table 69. Merck Company Details
  • Table 70. Merck Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 71. Merck Recent Development
  • Table 72. Abbott Laboratories Company Details
  • Table 73. Abbott Laboratories Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 74. Abbott Laboratories Recent Development
  • Table 75. Asahi Kasei Company Details
  • Table 76. Asahi Kasei Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 77. Asahi Kasei Recent Development
  • Table 78. Biogen Company Details
  • Table 79. Biogen Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 80. Koneksa Health Company Details
  • Table 81. Koneksa Health Digital Biomarker Product
  • Table 82. Koneksa Health Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 83. Koneksa Health Recent Development
  • Table 84. Roche Company Details
  • Table 85. Roche Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 86. Huma Therapeutics Company Details
  • Table 87. Huma Therapeutics Revenue in Digital Biomarker Business (2020-2022) & (US$ Million)
  • Table 88. Huma Therapeutics Recent Development
  • Table 89. Research Programs/Design for This Report
  • Table 90. Key Data Information from Secondary Sources
  • Table 91. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Digital Biomarker Market Share by Type: 2021 VS 2028
  • Figure 2. Global Digital Biomarker Market Share by Application: 2021 VS 2028
  • Figure 3. Digital Biomarker Report Years Considered
  • Figure 4. Global Digital Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 5. Global Digital Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 6. Global Digital Biomarker Market Share by Region: 2021 VS 2028
  • Figure 7. Global Digital Biomarker Market Share by Players in 2021
  • Figure 8. Global Top Digital Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biomarker as of 2021)
  • Figure 9. The Top 3 and 5 Players Market Share by Digital Biomarker Revenue in 2021
  • Figure 10. North America Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 11. North America Digital Biomarker Market Share by Type (2017-2028)
  • Figure 12. North America Digital Biomarker Market Share by Application (2017-2028)
  • Figure 13. North America Digital Biomarker Market Share by Country (2017-2028)
  • Figure 14. United States Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 15. Canada Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 16. Europe Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 17. Europe Digital Biomarker Market Share by Type (2017-2028)
  • Figure 18. Europe Digital Biomarker Market Share by Application (2017-2028)
  • Figure 19. Europe Digital Biomarker Market Share by Country (2017-2028)
  • Figure 20. Germany Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. U.K. Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. France Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Russia Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Italy Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Asia-Pacific Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. Asia-Pacific Digital Biomarker Market Share by Type (2017-2028)
  • Figure 27. Asia-Pacific Digital Biomarker Market Share by Application (2017-2028)
  • Figure 28. Asia-Pacific Digital Biomarker Market Share by Region (2017-2028)
  • Figure 29. China Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Japan Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. South Korea Digital Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Bottom-up and Top-down Approaches for This Report
  • Figure 33. Data Triangulation
  • Figure 34. Key Executives Interviewed
目次

Market Analysis and Insights:

The global Digital Biomarker market size is projected to reach US$ 22357.91 million by 2028, from US$ 387.24 million in 2021, at a CAGR of 82.53% during 2022-2028.

Fully considering the economic change by this health crisis, Passive Digital Biomarker accounting for 65.55% of the Digital Biomarker global market in 2021, is projected to value US$ 15,176.55 million by 2028, growing at a revised 83.46% CAGR in the post-COVID-19 period. While Clinical Disease segment is altered to an 83.25% CAGR throughout this forecast period.

China Digital Biomarker market size is valued at US$ 24.86 million in 2021, while the North America and Europe Digital Biomarker are US$ 140.96 million and US$ 167.17 million, severally. The proportion of the North America is 36.40% in 2021, while China and Europe are 6.42% and 43.17% respectively, and it is predicted that China proportion will reach 6.08% in 2028, trailing a CAGR of 81.11% through the analysis period. Japan and South Korea are noteworthy markets in Asia, with CAGR 83.99%, and 72.81% respectively for the next 6-year period. As for the Europe Digital Biomarker landscape, Germany is projected to reach US$ 3,706.24 million by 2028 trailing a CAGR of 90.55% over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Biomarker market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Biomarker market.

Scope and Market Size:

Digital Biomarker market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

  • Philips
  • Johnson & Johnson
  • Pfizer
  • GE Healthcare
  • Novartis
  • Apple
  • Sanofi
  • GlaxoSmithKline
  • Bayer
  • Merck
  • Abbott Laboratories
  • Asahi Kasei
  • Biogen
  • Koneksa Health
  • Roche
  • Huma Therapeutics

Segment by Type

  • Passive Digital Biomarker
  • Active Digital Biomarker

Segment by Application

  • Clinical Disease
  • Daily Health

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Digital Biomarker Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
    • 1.2.2 Passive Digital Biomarker
    • 1.2.3 Active Digital Biomarker
  • 1.3 Market by Application
    • 1.3.1 Global Digital Biomarker Market Share by Application: 2017 VS 2021 VS 2028
    • 1.3.2 Clinical Disease
    • 1.3.3 Daily Health
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Digital Biomarker Market Perspective (2017-2028)
  • 2.2 Digital Biomarker Growth Trends by Region
    • 2.2.1 Digital Biomarker Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Digital Biomarker Historic Market Size by Region (2017-2022)
    • 2.2.3 Digital Biomarker Forecasted Market Size by Region (2023-2028)
  • 2.3 Digital Biomarker Market Dynamics
    • 2.3.1 Digital Biomarker Industry Trends
    • 2.3.2 Digital Biomarker Market Drivers
    • 2.3.3 Digital Biomarker Market Challenges and Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Digital Biomarker Players by Revenue
    • 3.1.1 Global Top Digital Biomarker Players by Revenue (2020-2022)
    • 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2020-2022)
  • 3.2 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Digital Biomarker Revenue
  • 3.4 Global Digital Biomarker Market Concentration Ratio
    • 3.4.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 3 and Top 5 Companies by Digital Biomarker Revenue in 2021
  • 3.5 Digital Biomarker Key Players Head office and Area Served
  • 3.6 Date of Establishment in Digital Biomarker Market
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 DIGITAL BIOMARKER BREAKDOWN DATA BY TYPE

  • 4.1 Global Digital Biomarker Historic Market Size by Type (2017-2022)
  • 4.2 Global Digital Biomarker Forecasted Market Size by Type (2023-2028)

5 DIGITAL BIOMARKER BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Digital Biomarker Historic Market Size by Application (2017-2022)
  • 5.2 Global Digital Biomarker Forecasted Market Size by Application (2023-2028)

6 NORTH AMERICA

  • 6.1 North America Digital Biomarker Market Size (2017-2028)
  • 6.2 North America Digital Biomarker Market Size by Type
    • 6.2.1 North America Digital Biomarker Market Size by Type (2017-2022)
    • 6.2.2 North America Digital Biomarker Market Size by Type (2023-2028)
    • 6.2.3 North America Digital Biomarker Market Share by Type (2017-2028)
  • 6.3 North America Digital Biomarker Market Size by Application
    • 6.3.1 North America Digital Biomarker Market Size by Application (2017-2022)
    • 6.3.2 North America Digital Biomarker Market Size by Application (2023-2028)
    • 6.3.3 North America Digital Biomarker Market Share by Application (2017-2028)
  • 6.4 North America Digital Biomarker Market Size by Country
    • 6.4.1 North America Digital Biomarker Market Size by Country (2017-2022)
    • 6.4.2 North America Digital Biomarker Market Share by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 EUROPE

  • 7.1 Europe Digital Biomarker Market Size (2017-2028)
  • 7.2 Europe Digital Biomarker Market Size by Type
    • 7.2.1 Europe Digital Biomarker Market Size by Type (2017-2022)
    • 7.2.2 Europe Digital Biomarker Market Size by Type (2023-2028)
    • 7.2.3 Europe Digital Biomarker Market Share by Type (2017-2028)
  • 7.3 Europe Digital Biomarker Market Size by Application
    • 7.3.1 Europe Digital Biomarker Market Size by Application (2017-2022)
    • 7.3.2 Europe Digital Biomarker Market Size by Application (2023-2028)
    • 7.3.3 Europe Digital Biomarker Market Share by Application (2017-2028)
  • 7.4 Europe Digital Biomarker Market Size by Country
    • 7.4.1 Europe Digital Biomarker Market Size by Country (2017-2022)
    • 7.4.2 Europe Digital Biomarker Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 U.K.
    • 7.4.5 France
    • 7.4.6 Russia
    • 7.4.7 Italy

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Digital Biomarker Market Size (2017-2028)
  • 8.2 Asia-Pacific Digital Biomarker Market Size by Type
    • 8.2.1 Asia-Pacific Digital Biomarker Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Digital Biomarker Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Digital Biomarker Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Digital Biomarker Market Size by Application
    • 8.3.1 Asia-Pacific Digital Biomarker Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Digital Biomarker Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Digital Biomarker Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Digital Biomarker Market Size by Region
    • 8.4.1 Asia-Pacific Digital Biomarker Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Digital Biomarker Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea

9 KEY PLAYERS PROFILES

  • 9.1 Philips
    • 9.1.1 Philips Company Details
    • 9.1.2 Philips Business Overview
    • 9.1.3 Philips Digital Biomarker Introduction
    • 9.1.4 Philips Revenue in Digital Biomarker Business (2020-2022)
    • 9.1.5 Philips Recent Development
  • 9.2 Johnson & Johnson
    • 9.2.1 Johnson & Johnson Company Details
    • 9.2.2 Johnson & Johnson Business Overview
    • 9.2.3 Johnson & Johnson Digital Biomarker Introduction
    • 9.2.4 Johnson & Johnson Revenue in Digital Biomarker Business (2020-2022)
    • 9.2.5 Johnson & Johnson Recent Development
  • 9.3 Pfizer
    • 9.3.1 Pfizer Company Details
    • 9.3.2 Pfizer Business Overview
    • 9.3.3 Pfizer Digital Biomarker Introduction
    • 9.3.4 Pfizer Revenue in Digital Biomarker Business (2020-2022)
    • 9.3.5 Pfizer Recent Development
  • 9.4 GE Healthcare
    • 9.4.1 GE Healthcare Company Details
    • 9.4.2 GE Healthcare Business Overview
    • 9.4.3 GE Healthcare Digital Biomarker Introduction
    • 9.4.4 GE Healthcare Revenue in Digital Biomarker Business (2020-2022)
    • 9.4.5 GE Healthcare Recent Development
  • 9.5 Novartis
    • 9.5.1 Novartis Company Details
    • 9.5.2 Novartis Business Overview
    • 9.5.3 Novartis Digital Biomarker Introduction
    • 9.5.4 Novartis Revenue in Digital Biomarker Business (2020-2022)
    • 9.5.5 Novartis Recent Development
  • 9.6 Apple
    • 9.6.1 Apple Company Details
    • 9.6.2 Apple Business Overview
    • 9.6.3 Apple Digital Biomarker Introduction
    • 9.6.4 Apple Revenue in Digital Biomarker Business (2020-2022)
  • 9.7 Sanofi
    • 9.7.1 Sanofi Company Details
    • 9.7.2 Sanofi Business Overview
    • 9.7.3 Sanofi Digital Biomarker Introduction
    • 9.7.4 Sanofi Revenue in Digital Biomarker Business (2020-2022)
  • 9.8 GlaxoSmithKline
    • 9.8.1 GlaxoSmithKline Company Details
    • 9.8.2 GlaxoSmithKline Business Overview
    • 9.8.3 GlaxoSmithKline Digital Biomarker Introduction
    • 9.8.4 GlaxoSmithKline Revenue in Digital Biomarker Business (2020-2022)
    • 9.8.5 GlaxoSmithKline Recent Development
  • 9.9 Bayer
    • 9.9.1 Bayer Company Details
    • 9.9.2 Bayer Business Overview
    • 9.9.3 Bayer Digital Biomarker Introduction
    • 9.9.4 Bayer Revenue in Digital Biomarker Business (2020-2022)
    • 9.9.5 Bayer Recent Development
  • 9.10 Merck
    • 9.10.1 Merck Company Details
    • 9.10.2 Merck Business Overview
    • 9.10.3 Merck Digital Biomarker Introduction
    • 9.10.4 Merck Revenue in Digital Biomarker Business (2020-2022)
    • 9.10.5 Merck Recent Development
  • 9.11 Abbott Laboratories
    • 9.11.1 Abbott Laboratories Company Details
    • 9.11.2 Abbott Laboratories Business Overview
    • 9.11.3 Abbott Laboratories Digital Biomarker Introduction
    • 9.11.4 Abbott Laboratories Revenue in Digital Biomarker Business (2020-2022)
    • 9.11.5 Abbott Laboratories Recent Development
  • 9.12 Asahi Kasei
    • 9.12.1 Asahi Kasei Company Details
    • 9.12.2 Asahi Kasei Business Overview
    • 9.12.3 Asahi Kasei Digital Biomarker Introduction
    • 9.12.4 Asahi Kasei Revenue in Digital Biomarker Business (2020-2022)
    • 9.12.5 Asahi Kasei Recent Development
  • 9.13 Biogen
    • 9.13.1 Biogen Company Details
    • 9.13.2 Biogen Business Overview
    • 9.13.3 Biogen Digital Biomarker Introduction
    • 9.13.4 Biogen Revenue in Digital Biomarker Business (2020-2022)
  • 9.14 Koneksa Health
    • 9.14.1 Koneksa Health Company Details
    • 9.14.2 Koneksa Health Business Overview
    • 9.14.3 Koneksa Health Digital Biomarker Introduction
    • 9.14.4 Koneksa Health Revenue in Digital Biomarker Business (2020-2022)
    • 9.14.5 Koneksa Health Recent Development
  • 9.15 Roche
    • 9.15.1 Roche Company Details
    • 9.15.2 Roche Business Overview
    • 9.15.3 Roche Digital Biomarker Introduction
    • 9.15.4 Roche Revenue in Digital Biomarker Business (2020-2022)
  • 9.16 Huma Therapeutics
    • 9.16.1 Huma Therapeutics Company Details
    • 9.16.2 Huma Therapeutics Business Overview
    • 9.16.3 Huma Therapeutics Digital Biomarker Introduction
    • 9.16.4 Huma Therapeutics Revenue in Digital Biomarker Business (2020-2022)
    • 9.16.5 Huma Therapeutics Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

  • 11.1 Research Methodology
    • 11.1.1 Methodology/Research Approach
    • 11.1.2 Data Source
  • 11.2 Disclaimer
  • 11.3 Author Details